MAIA Biotechnology, Inc. (MAIA) Income Statement
MAIA 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsMAIA revenue and net income
MAIA growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
MAIA quarterly EPS vs estimates
MAIA Biotechnology beat the analyst EPS estimate in 5 of the last 8 quarters. Next report: November 6, 2026 (estimate $-0.13).
MAIA income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & development | $14.55B | $10.0M | $11.1M | $8.9M | $3.5M | $1.4M | $1.9M |
| Sales, general & admin | $9.72B | $6.9M | $9.1M | $6.1M | $4.3M | $5.6M | $5.0M |
| Total operating expenses | $24.3M | $17.0M | $20.2M | $16.2M | $7.8M | $7.0M | $6.9M |
| Operating income | −$24.3M | −$17.0M | −$20.2M | −$16.2M | −$7.8M | −$7.0M | −$6.9M |
| Interest income | $313,954 | $318,367 | $34,490 | $1,870 | $2,012 | $679 | — |
| Interest expense | $0 | $57 | $6,863 | $6,967 | $827,539 | $31,547 | $0 |
| Income before taxes | −$22.4M | −$23.3M | −$19.8M | −$15.8M | −$12.6M | −$7.0M | −$6.9M |
| Income taxes | — | −$79,954 | −$176,719 | $36,689 | $707,530 | −$291,000 | −$435,000 |
| Net income | −$22.4M | −$23.3M | −$19.8M | −$15.8M | −$12.5M | −$6.6M | −$6.5M |
| EBITDA | −$22.4M | −$23.3M | −$19.8M | −$15.8M | −$11.8M | −$7.0M | $242 |
| EPS (diluted) | −$0.75 | −$1.29 | −$1.49 | −$1.93 | −$1.18 | −$0.62 | — |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & development | $5.6M | $3.5M | $1.9M | $6.4M | $3.1M | $3.2M | $3.0M | $2.7M | $2.1M | $2.3M | $3.7M | $2.6M |
| Sales, general & admin | $2.7M | $3.4M | $2.4M | $3.0M | $2.1M | $2.2M | $2.0M | $1.5M | $1.8M | $1.6M | $2.7M | $2.4M |
| Total operating expenses | $8.3M | $6.9M | $4.3M | $9.4M | $5.2M | $5.4M | $5.0M | $4.2M | $3.8M | $3.9M | $6.4M | $5.0M |
| Operating income | −$8.3M | −$6.9M | −$4.3M | −$9.4M | −$5.2M | −$5.4M | −$5.0M | −$4.2M | −$3.8M | −$3.9M | −$6.4M | −$5.0M |
| Interest income | $236,320 | $111,757 | $73,648 | $78,426 | $79,697 | $82,183 | $79,784 | $106,082 | $88,383 | $44,118 | $30,722 | $3,260 |
| Interest expense | — | — | $0 | $0 | — | — | $28 | $85 | $0 | $0 | $13,726 | $1 |
| Income before taxes | −$7.6M | −$6.4M | −$3.6M | −$8.9M | −$5.3M | −$4.5M | −$3.6M | −$2.7M | −$8.9M | −$8.1M | −$6.3M | −$4.9M |
| Income taxes | $373,664 | — | — | — | — | — | −$28,107 | — | −$18,048 | −$18,601 | −$27,262 | −$61,707 |
| Net income | −$7.9M | −$6.4M | −$3.6M | −$8.9M | −$5.3M | −$4.5M | −$3.6M | −$2.7M | −$8.9M | −$8.1M | −$6.3M | −$4.9M |
| EBITDA | −$7.6M | −$6.4M | −$3.6M | $457,737 | −$5.3M | −$4.5M | $1.4M | −$2.7M | −$3.8M | −$3.9M | −$6.3M | −$4.9M |
| EPS (diluted) | −$0.13 | −$0.14 | −$0.14 | −$0.27 | −$0.18 | −$0.16 | −$0.32 | −$0.11 | −$0.40 | −$0.46 | −$0.40 | −$0.36 |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in MAIA's financial statements (latest annual report filed March 23, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
MAIA financial results
MAIA Biotechnology reported no revenue in fiscal year 2025 (ended December 31, 2025). It had a net loss of $22.4 million. Diluted earnings per share came to −$0.75.
See the MAIA stock overview for the latest quote and news, or the MAIA chart for price history and technical indicators.
MAIA income statement FAQ
Does MAIA Biotechnology have revenue?
MAIA Biotechnology reported no revenue for fiscal year 2025, which ended on December 31, 2025.
Is MAIA Biotechnology profitable?
No. MAIA Biotechnology reported a net loss of $22.4 million in fiscal 2025.
How much does MAIA Biotechnology spend on research and development?
MAIA Biotechnology spent $14.5 billion on research and development in fiscal 2025.
What are MAIA Biotechnology's earnings per share?
MAIA Biotechnology earned $-0.75 per diluted share in fiscal 2025, compared with $-1.29 a year earlier.
When will MAIA Biotechnology report its next earnings?
MAIA Biotechnology is expected to report results for the quarter ending September 30, 2026 on November 6, 2026.
When does MAIA Biotechnology's fiscal year end?
MAIA Biotechnology's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 23, 2026.